...
首页> 外文期刊>The Biochemical Journal >Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and ups
【24h】

Functional specificity of two hormone response elements present on the human apoA-II promoter that bind retinoid X receptor alpha/thyroid receptor heterodimers for retinoids and thyroids: synergistic interactions between thyroid receptor beta and ups

机译:存在于人apoA-II启动子上的两种激素反应元件的功能特异性,它们与类视色素和甲状腺结合类视黄醇X受体α/甲状腺受体异二聚体:甲状腺受体β与ups之间的协同相互作用

获取原文
获取原文并翻译 | 示例
           

摘要

DNA binding and mutagenesis in vitro established that the -67/-55 region of the apoA-II (apolipoprotein A-II) promoter contains a thyroid HRE (hormone response element), which strongly binds RXRalpha (retinoid X receptor alpha)/T(3)Rbeta (thyroid receptor beta) heterodimers and weakly T(3)Rbeta homodimers, but does not bind other homo- or heterodimers of RXRalpha or orphan nuclear receptors. Transactivation was abolished by point mutations in the thyroid HRE. In co-transfection experiments of HEK-293 (human embryonic kidney 293) cells, the -911/+29 human apoA-II promoter was transactivated strongly by RXRalpha/T(3)Rbeta heterodimers in the presence of RA (9-cis retinoic acid) or T-3 (tri-iodothyronine). Homopolymeric promoters containing either three copies of the - 73/- 40 (element AIIAB) or four copies of the - 738/-712 (element AIIJ) apoA-II promoter could be transactivated by RXRalpha/T(3)Rbeta heterodimers in COS-7 cells only in the presence of T, or RA respectively. RXRalpha/T(3)Rbeta heterodimers and USF2a (upstream stimulatory factor 2a) synergistically transactivated the - 911/ + 29 apoA-II promoter in the presence of T-3. USF2a also enhanced the activity of a GAL4-T(3)Rbeta fusion protein in the presence of T3 and suppressed the activity of a GAL4-RXRalpha fusion protein in the presence of RA. These findings suggest a functional specificity of the two HREs of the apoA-II promoter for retinoids and thyroids, which is modulated by synergistic or antagonistic interactions between RXRalpha/T(3)Rbeta heterodimers and the ubiquitous transcription factor USF2a.
机译:体外DNA结合和诱变确定apoA-II(载脂蛋白A-II)启动子的-67 / -55区含有一个甲状腺HRE(激素反应元件),它与RXRalpha(类维生素X受体alpha)/ T( 3)Rbeta(甲状腺受体β)异二聚体和弱T(3)Rbeta同二聚体,但不结合RXRalpha或孤儿核受体的其他同二聚体或异二聚体。甲状腺HRE中的点突变取消了反式激活。在HEK-293(人类胚胎肾293)细胞的共转染实验中,在存在RA(9-顺式视黄酸)的情况下,RXRalpha / T(3)Rbeta异二聚体强烈地激活了-911 / + 29人apoA-II启动子酸)或T-3(三碘甲状腺素)。包含三拷贝-73 /-40(元素AIIAB)或四拷贝-738 / -712(元素AIIJ)apoA-II启动子的均聚物启动子可以被RXRalpha / T(3)Rbeta异二聚体在COS-仅在T或RA的存在下有7个细胞。 RXRalpha / T(3)Rbeta异二聚体和USF2a(上游刺激因子2a)在T-3存在下协同反式激活-911 / + 29 apoA-II启动子。 USF2a还可以在T3存在的情况下增强GAL4-T(3)Rbeta融合蛋白的活性,并在RA存在的情况下抑制GAL4-RXRalpha融合蛋白的活性。这些发现表明apoA-II启动子的两个HRE对类维生素A和甲状腺的功能特异性,这是由RXRalpha / T(3)Rbeta异二聚体和普遍存在的转录因子USF2a之间的协同或拮抗相互作用所调节的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号